Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:123-130

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wickman, A.
Right arrow Articles by Isgaard, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wickman, A.
Right arrow Articles by Isgaard, J.

(Hypertension. 1997;29:123.)
© 1997 American Heart Association, Inc.


Research Articles (Issue 1, Part 1)

Induction of Growth Hormone Receptor and Insulin-Like Growth Factor-I mRNA in Aorta and Caval Vein During Hemodynamic Challenge

Anna Wickman; Peter Friberg; Michael A. Adams; Göran L. Matejka; Camilla Brantsing; Gregor Guron; Jörgen Isgaard

the Department of Physiology, Institute of Physiology/Pharmacology (A.W., P.F., G.G.), and Research Center for Endocrinology and Metabolism, Department of Internal Medicine (G.L.M., C.B., J.I.), University of Göteborg (Sweden); and Department of Pharmacology/Toxicology, Queens University, Kingston, Ontario, Canada (M.A.A.).

Induction of two-kidney, one clip hypertension (renal hypertension) is characterized by a slow increase in left ventricular tension and aortic wall stress, as opposed to aortocaval fistula or shunt volume overload, which induces a marked and rapid onset of wall stress in the caval vein and right ventricle. In the present study, we applied hemodynamic challenge to study the growth response involving gene expression of insulin-like growth factor-I (IGF-I) and growth hormone receptor (GH-R) mRNA in aorta and caval vein. Volume overload and pressure overload were induced in Wistar rats by means of shunt and renal hypertension, respectively. Systolic pressure was measured before excision of the great vessels, which was performed between 2 and 12 days postoperatively. Aortic and caval vein IGF-I and GH-R mRNA expressions were measured by means of a solution hybridization assay, and the caval vein was analyzed for IGF-I protein by immunohistochemistry. In the volume-distended but not pressurized caval vein in shunt rats, verified by telemetry recordings, there was an eightfold increase in IGF-I and 3.5-fold increase in GH-R mRNA at day 4 versus control. The IGF-I protein appeared to be localized in smooth muscle cells. In the aorta of the renal hypertension group, changes were of a slower onset. At day 7, there was a fourfold increase in IGF-I and fivefold increase of GH-R mRNA expressions versus sham-operated rats. Both the shunt caval vein and renal hypertension aorta showed evidence of a structural adaptation of the growth response. The present study suggests that acute elevation in vascular wall stress is an important triggering factor for overexpression of IGF-I and GH-R mRNA in great vessels. The growth hormone/insulin-like growth factor axis may be an important link in mediating structurally adaptive growth responses in the blood vessel wall.


Key Words: insulin-like growth factor I • growth substances • hypertension, renal • fistula • hemodynamics • rats




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
C. Ohlsson, S. Mohan, K. Sjogren, A. Tivesten, J. Isgaard, O. Isaksson, J.-O. Jansson, and J. Svensson
The Role of Liver-Derived Insulin-Like Growth Factor-I
Endocr. Rev., August 1, 2009; 30(5): 494 - 535.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
E. R. Schwarz, P. Jammula, R. Gupta, and S. Rosanio
A Case and Review of Acromegaly-Induced Cardiomyopathy and the Relationship Between Growth Hormone and Heart Failure: Cause or Cure or Neither or Both?
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2006; 11(4): 232 - 244.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Delafontaine, Y.-H. Song, and Y. Li
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444.
[Abstract] [Full Text]


Home page
StrokeHome page
A.F.C. Schut, J.A.M.J.L. Janssen, J. Deinum, J.M. Vergeer, A. Hofman, S.W.J. Lamberts, B.A. Oostra, H.A.P. Pols, J.C.M. Witteman, and C.M. van Duijn
Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension
Stroke, July 1, 2003; 34(7): 1623 - 1627.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown
Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats
Hypertension, December 1, 1999; 34(6): 1215 - 1222.
[Abstract] [Full Text] [PDF]